2. Overview
⢠Introduction
⢠Historical perspective
⢠Sleep Physiology
⢠Classification systems of sleep disorders
⢠Parasomnias- NREM , REM & other
⢠Take home message
⢠References
2
3. Introduction
⢠Sleep
â State of decreased awareness
â Fundamental
â 1/3 lifespan
â Sleep and Psychiatry
Kaplan and Saddock, Comprehensive Textbook of Psychiatry, 9 edn
4. History of sleep study
⢠Ancient Gk â Hypnos & Morpheus
⢠Hippocrates (GK) Blood retreating to internal organs
⢠1830- Robert MacNish- temporary metaphysical death
⢠1868- Wilhelm Griesinger- eyelids flutter during sleep
(active)
Kaplan and Saddock, Synopsis of Psychiatry,11th edn, 2015
http://healthysleep.med.harvard.edu/interactive/timeline
5. History of sleep study â Modern era
⢠1929- Hans Berger â EEG
⢠1953- N Kleitman and Eugene Aserinsky
Âťdiscovered REM sleep
⢠1955-58 - Wilhelm Dement â sleep cycles
⢠REM sleep â dreams
⢠1968 â Allen Rechtschenaffen and Anthony Kales
⢠Scoring system for sleep stages â EEG/EMG/EOG
http://healthysleep.med.harvard.edu/interactive/timeline
6. Basic Sleep Physiology-
Types, stages and cycle
⢠Types
â REM / Paradoxical / Active
â NREM / Orthodox / Quiet
⢠Stages
â NREM- N1, N2 & N3
â REM (components) â Tonic & Phasic
⢠Sleep Cycle
â Changes in sleep stages over time (night)
Kaplan and Saddock, Comprehensive Textbook of Psychiatry, 9 edn
7. Stages of sleep
EEG EOG EMG
N1
transit
ional
Îą ď θ
N2 K âcomplexes and Sleep
spindles
-----
N3, Î
SWS
Î (20%) ----- Low tonic
activity
REM Low voltage, mixed ν; saw
toothed; θ ; ι.
REM Tonic- atonia
Phasic - twitches
Low tonic activity
Kaplan and Saddock, Comprehensive Textbook of Psychiatry, 9 edn
11. ICD 10 Classification of Sleep Disorders
⢠Organic vs non-organic
⢠Organic â Diseases of the Nervous system
â Episodic and paroxysmal disorders (G40-G47)
⢠Sleep disorders (G47)
⢠G47.5 - Parasomnia
â˘G47.50 - Parasomnia, unspecified
â˘G47.51 - Confusional arousals
â˘G47.52 - REM sleep behavior disorder
â˘G47.53 - Recurrent isolated sleep paralysis
â˘G47.54 - Parasomnia in conditions classified elsewhere
â˘G47.59 - Other parasomnia
12. ICD 10 Classification of Sleep Disorders
⢠Non-Organic sleep disorders
â F51.0 â Non organic insomnia
â F51.1- Non-organic hypersomnia
â F51.2- Non organic disorder of the sleep-wake schedule
â F51.3- Sleep walking
â F51.4- Sleep terrors
â F51.5- Nightmares
â F51.8- Other non-organic sleep disorders
â F51.9- Non-organic sleep disorder, unspecified
13. ICSD -3 (2014) - AASM
⢠Insomnia
⢠Sleep related breathing disorders
⢠Central disorders of hyper-somnolence
⢠Circadian rhythm sleep wake disorders
⢠Parasomnias
⢠Sleep related movement disorders
⢠Other sleep disorders
Sateia MJ. International classification of sleep disorders-third edition: highlights and
modifications. Chest 2014; 146:1387.
14. ICSD -3 (2014) â AASM
Parasomnias
⢠Disorders of arousal (from NREM sleep)
â Confusional arousals
â Sleep walking
â Sleep terrors
â Sleep related eating disorders
Sateia MJ. International classification of sleep disorders-third edition: highlights and
modifications. Chest 2014; 146:1387.
15. ICSD -3 (2014) â AASM
Parasomnias
⢠Parasomnias usually associated with REM sleep
â REM sleep related behavior disorder
â Recurrent Isolated Sleep paralysis
â Nightmares
Sateia MJ. International classification of sleep disorders-third edition: highlights and
modifications. Chest 2014; 146:1387.
16. ICSD -3 (2014) â AASM
Parasomnias
⢠Other Parasomnias
â Exploding head Syndrome
â Sleep related hallucinations
â Sleep enuresis
â Parasomnias due to medical condition
â Parasomnias due to substance/drug abuse
â Parasomnias - unspecified
Sateia MJ. International classification of sleep disorders-third edition: highlights and
modifications. Chest 2014; 146:1387.
17. DSM 5
Sleep wake disorders
⢠Insomnia disorder
⢠Hyper-somnolence disorder
⢠Narcolepsy
⢠Breathing related sleep disorders
⢠Circadian rhythm sleep wake disorders
⢠Parasomnias
⢠Restless leg syndrome
⢠Substance / medication induced sleep disorder
18. DSM -5
Parasomnias
â NREM sleep arousal disorder
⢠Sleep walking
⢠Sleep terror
â REM sleep related parasomnias
⢠Nightmare disorder
⢠REM sleep Behavior disorder
20. Definition
⢠DSM 5-
Disorders characterized by abnormal
behavioral, experiential or physiological
events occurring in assoc with sleep, specific
sleep stages or sleep wake transitions
⢠Para â along side
⢠Somnus- sleep
DSM-5, 2013, American Psychiatric Association
21. Parasomnias
⢠Disorders of partial arousal
⢠Physiological or behavioral phenomena that occur
during or are potentiated by sleep
⢠Intrusions of one basic sleepâwake state into another
⢠State boundary violations
⢠Clinical significance â
â Consequences /distress > frequency
Kaplan and Saddock, Comprehensive Textbook of Psychiatry, 9 edn
23. Disorders of Arousal (From NREM Sleep)
⢠Confusional arousals, sleepwalking, and sleep terrors
lie on a continuum
⢠Confusional arousals
â Mildest
â Children (<5 yrs)
â partially awaken from SWS and sit up
â Confusion
â lies back down and resumes sleep
Kaplan and Saddock, Comprehensive Textbook of Psychiatry, 9 edn
24. Epidemiology
⢠Sleep walking
â˘10-30 % childrenâ once
â˘Sleep walking disorder- 1-5 %
⢠Sleep terrors
â˘Sleep terror disorder- Prevalence- Not Known
â˘Sleep terror episodes
⢠18 months- 36.9 %
⢠30 months- 19.7 %
⢠Adults - 2.2 %
DSM-5, 2013, American Psychiatric Association
25. Pathophysiology
⢠Active: Motor cortex
⢠Inactive: Prefrontal & Mid-temporal
⢠SPECT studies- During a Sleep Walking Episode
Increase blood flow:
- Cerebellum
- Posterior Cingulate Cortex
Decrease blood flow:
- Fronto-parietal cortex
Bassetti, Claudio; SPECT during sleepwalking. Lancet. 356(9228):484-485, August 5, 2000
26. Pathophysiology
⢠Environmental factors (reduced sleep/ disturbed
sleep/ tiredness/ stress) ď lack of SWS sleep
⢠Rebound sleep with prolonged SWS/deep sleep
provides âfertile ground for such partial arousalsâ
Rutterâs Child and Adolescent Psychiatry, 6th edn, 2015
27. Risk Factors - Environmental
âDrugs (anti-depressants- TCA, Trazodone& Mirtazapine)
(non-BZD sedatives ie Zolpidem & Zopiclone)
âSleep deprivation
âSleep wake cycle disruption
âStress â physiological and psychological
âFatigue
DSM-5, 2013, American Psychiatric Association
Lara Kierlin, and Michael R. Littner, Parasomnias and antidepressant therapy: a review of the
literature, 2011 Frontiers in psychiatry
28. Risk Factors - Genetic and physiological
⢠Sleep walking-
â Family history (80 %)
â Risk increases if both parents +
⢠Sleep Terrors
⢠Family history (SW/ST)
⢠First degree relatives- 10x
⢠Twins - Mz 6x > Dz
⢠Exact Mechanism ??
--Bakwin H. Sleep-walking in twins. Lancet 1970; 2:446.
--Hublin C, Kaprio J. Genetic aspects and genetic epidemiology of parasomnias. Sleep Med Rev
2003; 7:413
--DSM-5, 2013, American Psychiatric Association
-- Petit D, Pennestri MH, Paquet J, et al. Childhood Sleepwalking and Sleep Terrors: A
Longitudinal -Study of Prevalence and Familial Aggregation. JAMA Pediatr 2015; 169:653
29. DSM-5 criteria
Disorders of Arousal (From NREM Sleep)
A) Recurrent episodes of âincomplete awakeningsâ
⢠First 1/3 , accompanied by 1 of following:
âSleep walking
âSleep terrors
B) Little or no dream imagery
C) Amnesia
D) Distress and socio-occupational impairment
E) Not d/t effects of a substance/drug
F) Not d/t other medical or mental condition
30. DSM-5 criteria
⢠Sleep walking:
repeated episodes
â Rising from bed &
walking around
(purposeful movt)
â Blank, staring face
â Relatively
unresponsive to
communication
â Difficult awakening
(deep sleep)
31. DSM-5 criteria
âSpecifiers:
A. Sleep related eating
â Recurrent unwanted
episodes of eating
â Amnesia - variable
â Inappropriate foods +
â Evidence â next
morning
32. DSM-5 criteria
âSpecifiers:
B. Sleep related sexual behavior (sexsomnia)
â Recurrent - varying degree of sexual activity
â Masturbation, fondling, groping & sexual intercourse
â Amnesia
â M>>F
â Problems : IP issues and Medico-legal
33. DSM-5 criteria
Sleep terrors: repeated
episodes
â Abrupt terror arousals
â Panicky scream
â Intense fear
â Autonomic hyperactivity
â Relatively unresponsive
to efforts to comfort
34. Course (NREM Parasomnias)
⢠Onset : Childhood
⢠Max around 4-6 years of age
⢠Decrease with age
⢠Fresh onset SW (adults)- Obstructive sleep apnoea
⢠Nocturnal seizures or
⢠drug induced
⢠Sleep terrors â children â no psychopathology
⢠Adults - h/o traumatic experience
⢠Psychiatric comorbidity
DSM-5, 2013, American Psychiatric Association
35. Diagnosis
⢠Video recording + Polysomnography
⢠PSG: ST and SW
âFirst 1/3
âDelta ď Theta/Alpha
DSM-5, 2013, American Psychiatric Association
36. Treatment
⢠PARENTS âReassurance
⢠CHILD- 1. Prevention of further attacks
âIdentify & Reduce environmental risk factors
âSleep hygiene
2. Before the episode- Safety
3. During an episode- Donât wake; re-direct
4. Long Term- Relaxation techniques
Anticipatory awakenings
Pharmac: Clonazepam & Melatonin
Kaplan and Saddock, Comprehensive Textbook of Psychiatry, 9 edn
Kap Schenck CH, Long-term, nightly benzodiazepine treatment of injurious parasomnias and
other disorders of disrupted nocturnal sleep in 170 adults. Am J Med. 1996
37. REM Sleep related Parasomnias
⢠REM Sleep behavior disorder (RBD)
⢠Nightmare disorder
⢠Recurrent isolated sleep paralysis
Kaplan and Saddock, Comprehensive Textbook of Psychiatry, 9 edn
40. Essentials
⢠Sleep paralysis (atonia)
â Îą and Îł â hypo-polarisation
⢠RBD- Absence of sleep paralysis
â Enactment of dreams- complex behaviors
â Second half of night
â Story like memory
â Unaware of surroundings
Kaplan and Saddock, Comprehensive Textbook of Psychiatry, 9 edn
41. Essentials
⢠RBD â Dream Enactment Behavior (DEB)
â Complex behaviors
â Running/jumping/leaping/punching/slapping
â Injuries to self or others
â Vocalisation / Somniloquy
⢠(loud, profane, emotionally charged)
Kaplan and Saddock, Comprehensive Textbook of Psychiatry, 9 edn
42. Epidemiology
⢠Prevalence - 0.38 â 0.50 %
⢠M > F
⢠>50 years
⢠Onset â gradual / rapid
⢠Course- progressive
⢠If assoc with Neuro-degenerative disease :
â RBD precedes by many years
â RBD improves as the disease progresses
DSM-5, 2013, American Psychiatric Association
43. Risk Factors
⢠Medicines â TCA /SSRI/SNRI/ β blockers
?? Cause or unmask
⢠REM rebound states assoc with alcohol & barbiturate
withdrawal
Kaplan and Saddock, Comprehensive Textbook of Psychiatry, 9 edn
44.
45. Diagnostic Criteria DSM 5
⢠Recurrent episodes, arousals from sleep associated
with vocalization and/or complex motor behaviors
⢠REM sleep/ > 90 min/ later part
⢠Upon awakening â alert and oriented
⢠Either â REM sleep+ NO atonia on PSG
âH/s/o RBD + estd synucleinopathy (PD, LBD)
⢠Distress / dysfunction
⢠Excl: drug/substance/co-existing mental/medical
DSM-5, American Psychiatric Association,2013
46. Diagnostic markers
⢠PSG + Video
⢠PSG - RSWA (REM sleep Without Atonia)
EEG â REM sleep
EMG â normal to increased tone
⢠Sub-mental
⢠B/L Extensor digitorum
⢠B/L Tibialis anterior
DSM-5, American Psychiatric Association,2013
47. Treatment - RBD
⢠Identify & remove the offending agent
⢠Modification of sleep environment ď Safety of Self and bed
partner -- Level A
â Mattresses on floor
â Window protection
â Padding corners of furniture
â Remove sharps
⢠Preventive - Customized pressurized bed alarm
--Aurora RN; Zak RS; Maganti RK Best Practice Guide for the Treatment of REM Sleep Behavior
Disorder (RBD). J Clin Sleep Med 2010;6 (http://www.aasmnet.org/resources)
--Devnani P, Fernandes R. Management of REM sleep behavior disorder : An evidence based
review. Ann Indian Acad Neurology. 2015 Jan-Mar; 18 (1): 1-5
48. Treatment - RBD
⢠Pharmacological
â BZD- Clonazepam (.25-2) mg QHS Level B
âMoA â suppression of phasic ms activity
⢠Melatonin - 3 to 12 mg QHS - Level B
restores atonia and improves symptoms
--Aurora RN; Zak RS; Maganti RK Best Practice Guide for the Treatment of rem sleep
behavior disorder (rbd). J Clin Sleep Med 2010;6
--Devnani P, Fernandes R. Management of REM sleep behavior disorder : An evidence
based review. Ann Indian Acad Neurology. 2015 Jan-Mar; 18 (1): 1-5
49. RBD and Neurodegenerative Disorders
⢠Risk of alpha synucleinopathies later in life (? prodrome) :
- Parkinsonâs Disease
- Dementia with Lewy Bodies
-Multiple system atrophy
⢠Thought to be related to the pathological involvement of
common brainstem structures including nigrostriatal
complex, locus coeruleus and raphe nucleus*
Iranzo A, Ferna´ndez-Arcos A, Tolosa E, Serradell M, Molinuevo JL, et al. (2014)
Neurodegenerative Disorder Risk in Idiopathic REM Sleep Behavior Disorder: Study in 174
Patients. PLoS ONE 9(2): e89741. doi:10.1371/journal.pone.0089741
* Iranzo A, Santamaria J, Tolosa E. The clinical and pathophysiological relevance of REM sleep
behavior disorder in neurodegenerative diseases. Sleep Med Rev 2009;13(6):385Y401.
51. Epidemiology
⢠Life time prevalence â 10-50%
⢠Content : F : sexual harassment / dying /disappearing
M: Aggression / war /terror
0
1
2
3
4
5
6
7
Childhood Adolescence Adulthood Elderly
Males
Female
52. Cause -Psycho-analytical perspective
⢠Emotionally charged dream â
â Process to de-fuse
â By disguising â symbol
â Preserves sleep
⢠Failure of this preventive dream process
Kaplan and Saddock, Comprehensive Textbook of Psychiatry, 9 edn
54. Diagnostic Criteria â DSM 5
⢠Repeated extended, extremely dysphoric and well
remembered dreams- efforts to avoid threats to
security/survival/physical integrity
⢠2nd half
⢠Awakening â alert & oriented
⢠Clinically significant distress /impairment
⢠Excl: substance / mental / medical disorder
DSM-5, 2013, American Psychiatric Association
55. Diagnostic Criteria â DSM 5
⢠Specify â based on onset and presentation
â Acute : < 1 month
â Sub-acute: 1-6 months
â Persistent: > 6 months
⢠Severity (frequency)
â Mild < 1/ wk
â Moderate >1 /wk - < 1 / night
â Severe Nightly
DSM-5, 2013, American Psychiatric Association
56. Associated Features
⢠Autonomic arousals â HR/RR/ sweating
⢠Body movts
⢠Vocalizations â PTSD, emotional stress, fragmented
sleep
⢠Frequent nightmares increase risk of suicide
⢠Idiopathic / secondary (PTSD, anxiety, substance etc)
⢠Replicative Nightmares- PTSD
DSM-5, 2013, American Psychiatric Association
57. Nightmare disorder- Vicious cycle
Nightmares
Increased
Frequency and
distress
Fear of
sleeping
Insomnia
Sleep
deprivation
Kaplan and Saddock, Comprehensive Textbook of Psychiatry, 9 edn
58. Diagnostic markers
PSG: abrupt awakening from REM sleep in 2nd
half of night
+
Reporting of nightmares
DSM-5, 2013, American Psychiatric Association
59. Treatment
⢠Identify risk factors- reduce / remove
⢠Psychological
â Sleep hygiene
â Lucid dream therapy
â Cognitive therapy (Image Rehearsal Therapy) Level A
â Systematic Desensitization and Progressive Muscle
Relaxation training - Level B
⢠Pharmacological
â Nefazodone
â Prazosin (PTSD associated Nightmares) - Level A
Kaplan and Saddock, Comprehensive Textbook of Psychiatry, 9 edn
Aurora RN; Best Practice Guide for the Treatment of Nightmare Disorder in Adults. J Clin Sleep
Med 2010;6(4) (http://www.aasmnet.org/resources)
60. Sleep hygiene
Dos Don'ts
Regular hrs -bedtime & arising Watch the clock to check insomnia
If hungry, take a light snack Exercise just before going to bed
Regular exercise Watch TV in bed before going to sleep
Cool, dark and quiet bedroom Take heavy meal before bedtime
Take coffee / tea/ cigarette in the
evening
If pre-occupied or worried â
write it down- deal with it next
morning
Use alcohol to sleep
Eat/ read/ exercise in bed, if cannot
sleep
Talk on phone/surf internet in bed
66. Nightmares Sleep terrors
Confusion Arousal with fear & autonomic
hyperactivity- may mimic Nightmares
Diff points-
Timing Later part First 1/3 of night
Imagery Vivid dream No / minimal
Awakening Complete,
oriented & aware
Partial; confused and partially
responsive to awakening, calming
Amnesia Not present +
Autonomic
activation
+ before
awakening
Sudden onset with the episode of
shouting/screaming
PSG REM NREM (N3)
DSM-5, 2013, American Psychiatric Association
67. RBD NREM parasomnias
Confusion Sleep walking and sleep
terrors may mimic RBD
Diff points-
Age Older, Males Younger
Timing Late Early, N3, difficult to awake
(deep sleep)
Awakening Easy, fully oriented &
aware
Difficult, confused,
disoriented
Recall + / story like Nil / minimal
PSG RSWA NREM, REM atonia
DSM-5, 2013, American Psychiatric Association
68. RBD Nocturnal seizures
(NFLE)
Confusion Vocalizations & automatism
may mimic RBD
Diff points-
Behavior Random, DEB,
varied
Stereotyped behavior
FLEP score < 0 >3
PSG+ full EEG
seizure
montage
RSWA REM sleep â atonia+
Focal Seizure +
DSM-5, 2013, American Psychiatric Association
71. Exploding Head Syndrome
⢠Paroxysmal sensory parasomnia
â˘âHearâ loud noise (? Auditory
hallucination) or
⢠Sense of a violent explosion in
the head
⢠About to fall asleep / nocturnal
awakening
â˘Sudden onset, brief
â˘No pain
â˘Autonomic
â˘Fear -- ?stroke or something is
very wrong
72. Exploding Head Syndrome
⢠Cause (?)
â Auditory hallucination assoc with RISP
â Assoc with Temporal lobe epilepsy??
⢠Gender: F>M,
⢠Age : >50 years
⢠Consequenceď insomnia +
⢠No known neurological consequences (benign)
⢠Treatment : Reassurance
âTCA
Frese A, Exploding head syndrome: six new cases and review of the literature, Cephalgia,
2014, Sep
74. Sleep Enuresis
⢠Consequences:
â Embarrassment, shame & guilt
⢠Treatment
⢠Pharmacological : Imipramine (TCA)
â oxybutynin (anticholinergic)
âsynthetic vasopressin (desmopressin)
⢠Behavioral :
âAnticipatory awakening
âBladder training using bell
âFluid restriction (?)
Kaplan and Saddock, Comprehensive Textbook of Psychiatry, 9 edn
75. Sleep Related Hallucinations
⢠Visual images
⢠Hypnagogic or hypnopompic
⢠Common in patients with
narcolepsy
⢠D/D dreams
⢠Abrupt awakening & without
remembrance dreaming
⢠Vivid and immobile and persists
for several minutes
76. Sleep-Related Groaning (Catathrenia)
⢠Prolonged, frequently loud groans
⢠Any sleep stage (up to 30 seconds)
⢠Begin during childhood (occult)
⢠Not related to psychiatric or physiologic abnormalities
⢠D/D snoring (inhalation); groaning (exhalation)
⢠No specific treatment
77. Parasomnias â Medical conditions
⢠Seizure disorder
â D/D sleep terror, sleepwalking, RBD, nightmares
⢠Sleep-related breathing disorders
â Can trigger - sleepwalking, enuresis, sleep terrors,
confusional arousal, and nightmares
⢠RBD is assoc with
Parkinson's disease, dementia, narcolepsy, MSA
78. Parasomnias âDrugs/substances
⢠Sleepwalking â Alcohol
⢠RBD provoked or worsened by
âREM sleep suppressants- TCA, MAOIs, caffeine,
SNRI (venlafaxine) and SSRI
âwithdrawal from alcohol, pentazocine (opioid) and
nitrazepam (BZD)
⢠Nightmares- L-DOPA and β-blockers.
â Drug-induced REM sleep rebound (e.g., withdrawal
from REM-suppressing drugs -methamphetamine)
â Alcohol abuse or withdrawal
79. Class Pharmacology Effects on sleep
TCA
5HT and NE
Re-uptake inhibition & H1 #
Decreased sleep latency
REM suppression
Increased REM latency
SSRI 5HT Re-uptake inhibition
REM suppression
Increased REM latency
SNRI
5HT and NE
Re-uptake inhibition
REM suppression
Increased REM latency
Trazodone
Nefazodone
5 HT-2 antagonism
Decreased sleep latency
Increased SWS
Mirtazapine 5 HT-2 and H1 antagonism
Decreased sleep latency
Increased SWS
Bupropion NE & DA reuptake inhibition Increased REM sleep
80. Take Home Message
⢠Parasomnias are boundary transgressions involving
abnormal behavioral, experiential and physiological
phenomena
⢠NREM parasomnias occur in N3- early/deep
sleep/childhood/ benign
⢠REM parasomnias âR-W boundary- absence or
extension of physiological phenomenon
â Late sleep / Adulthood - elderly/ May be harmful
⢠Psychotropic drugs can alter the sleep physiology
81. References
⢠Kaplan and Saddock, Comprehensive Textbook of Psychiatry,
9 edn, 2009
⢠DSM-5, American Psychiatric Association, 2013
⢠Sateia MJ. International classification of sleep disorders-
third edition: highlights and modifications. Chest 2014;
146:1387.
⢠Devnani P, Fernandes R. Management of REM sleep
behavior disorder : An evidence based review. Ann Indian
Acad Neurology. 2015 Jan-Mar; 18 (1): 1-5
⢠Kaplan and Saddock, Synopsis of Psychiatry,11th edn, 2015
I will be presenting the topic under the following headings
sleep is a state of decreased awareness of environmental stimuli that is distinguished from states such as coma or hibernation by its relatively rapid reversibility
Ancient Gk â Hypnos â god of sleep- -- causes sleep
& his son â Morpheus â caused dreams
N Kleitman -f/o American sleep research
Jennifer aniston
Parasomnias - disorders of partial arousal. the parasomnias are a diverse collection of sleep disorders characterized by physiological or behavioral phenomena that occur during or are potentiated by sleep. One conceptual framework posits many parasomnias as overlaps or intrusions of one basic sleepâwake state into another. Wakefulness, NREM sleep, and REM sleep can be characterized as three basic states that differ in their neurological organization. During wakefulness, both the body and brain are active. In NREM sleep, both the body and brain are much less active. REM sleep, however, pairs an atonic body with an active brain (capable of creating elaborate dream fantasies). Regional cerebral blood flow, magnetic resonance imaging (MRI), and other imaging studies confirm increased brain activation during REM sleep. It certainly appears that in some parasomnias there are state boundary violations. For example, all of the arousal disorders (confusional arousals, sleepwalking, and sleep terrors) involve momentary or partial wakeful behaviors suddenly occurring in NREM (slow wave) sleep. Similarly, isolated sleep paralysis is the persistence of REM sleep atonia into the wakefulness transition, whereas REM sleep behavior disorder is the failure of the mechanism creating paralytic atonia such that individuals literally act out their dreams
It is thought that confusional arousals, sleepwalking, and sleep terrors lie on a continuum
Confusional arousals are the mildest form of the three slow wave-sleepârelated parasomnias and are very common in young children. The child will typically partially awaken from slow wave sleep and sit up. The episodes are marked by confusion, but usually the child lies back down and resumes sleep.
Isolated or infrequent sleep walking is very common in general population with around 10-30 % children having had one episode of sleep walking and 2-3 % sleep walk often.
The prevalence of sleep walking disorder marked by significant distress or dysfunction is around 1-5 %
The prevalence of sleep terror disorder is not known.
However sleep terror episodes (not assoc with significant distress or dysfunction) is
18 months- 36.9 %
30 months- 19.7 %
Adults- 2.2 %
Overtiredness from any source (whether sleep deprivation, sleep disruption or erratic schedule) can increase or precipitate partial arousals. Any time a child is adjusting to getting less sleep, or has disturbed night-time sleep, the physiological compensation is to get deeper sleep (especially in the first 1â2 hours after sleep onset).
This deep ârecoveryâ sleep appears to be fertile ground for partial arousal events.
A second theme of associated features is in the realm of psychological and emotional factors. Particularly with respect to night terrors, much has been written about the association with particular psychological states, such as anxiety, trauma, stressful events and repressed aggression (Ferber, 1989; Klackenberg, 1982).
There are numerous case reports linking specific antidepressants to the various NREM sleep parasomnias, including reports of somnambulism with bupropion (Khazaal et al., 2003; Oulis et al., 2010), the noradrenergic and specific serotonergic tetracyclic mirtazapine (Yeh et al., 2009), paroxetine (Kawashima and Yamada, 2003), and the norepinephrine reuptake inhibitor reboxetine (KĂźnzel et al., 2004) â
Lam et al. (2008) also found increased sleepwalking in those using non-benzodiazepine hypnotics such as zolpidem and zopiclone thought to alter slow wave sleep and possibly leading to arousal disturbances in NREM sleep due to this property
REVIEW ARTICLE published: 12 December 2011 doi: 10.3389/fpsyt.2011.00071 Parasomnias and antidepressant therapy: a review of the literature Lara Kierlin1,2 and Michael R. Littner 1,2*
The events can last from a few seconds to 20 min, with an average duration of about 3 min. The termination is usually as sudden as the initiation,
with a rapid return to deep sleep. During the events, the children may seem confused, often not recognizing their parents, being inconsolable and often appearing incoherent
Amnesia in sleep related eating disorder may vary from no awareness to full awareness without the ability to not eat.
Fresh onset SW (adults)- ??Organic cause - Obstructive sleep apnoea, Nocturnal seizures or drug induced
Psychiatric comorbidity âpsychotic illness
Both PSG and video recording of the event are mandatory for diag of SW & ST. In PSG during both sleep terrors and sleep walking episode the delta wave of SWS is replaced by a theta or an alpha wave pattern indicated a partial awakening.
Safety â ground bedding,, padding of corners, locking of doors and windows, removal of sharps and dangerous objects from the room
There are two important aspects of REM sleep
Paralysis /ms atonia ď if not there â RBD, /// if transgresses the sleep-wake boundary into the wake stage ď RISP
REM â dreams which if become long, frightening and involve attempts to avoid threat to self ď nightmares
In 2010, AASM came with their best practice guidelines- Summary of Recommendations: Modifying the sleep environment is recommended for the treatment of patients with RBD who have sleep-related injury- (Level A- recommended)
A customized bed alarm pacifying patients with a calming phrase prevented falls in 4 medically refractory RBD patients during vigorous dream enactment behavior. Pre-treatment: 5 serious events, 80 minor events, and 193 near events were observed in over 66 patient-months (4.21events/pt-mo). Post-treatment improvement was noted after a follow up period of 63 pt-months with a marked reduction in events (0.05 event/pt-mo)
Clonazepam -treatment of RBD (Level B- suggested)----- (caution- dementia, gait disorders, or concomitant OSA).
use to be monitored carefully over time as RBD appears to be a precursor to neurodegenerative disorders with dementia .
Melatonin is suggested for the treatment of RBD with the advantage that there are few side effects. (Level B)
The cohort comprises 174 patients with a median age at diagnosis of IRBD of 69 years and a median follow-up of four years. The risk of a defined neurodegenerative syndrome from the time of IRBD diagnosis was 33.1% at five years, 75.7% at ten years, and 90.9% at 14 years. The median conversion time was 7.5 years. Emerging diagnoses (37.4%) were dementia with Lewy bodies (DLB) in 29 subjects, Parkinson disease (PD) in 22, multiple system atrophy (MSA) in two, and mild cognitive impairment (MCI) in 12. In six cases, in whom postmortem was performed, neuropathological examination disclosed neuronal loss and widespread Lewy-type pathology in the brain in each case
The cohort comprises 174 patients with a median age at diagnosis of IRBD of 69 years and a median follow-up of four years. The risk of a defined neurodegenerative syndrome from the time of IRBD diagnosis was 33.1% at five years, 75.7% at ten years, and 90.9% at 14 years. The median conversion time was 7.5 years. Emerging diagnoses (37.4%) were dementia with Lewy bodies (DLB) in 29 subjects, Parkinson disease (PD) in 22, multiple system atrophy (MSA) in two, and mild cognitive impairment (MCI) in 12. In six cases, in whom postmortem was performed, neuropathological examination disclosed neuronal loss and widespread Lewy-type pathology in the brain in each case
Conclusion. IRBD represented the prodromal period of these conditions. Our findings in IRBD have important implications in clinical practice, in the investigation of the early pathological events occurring in the synucleinopathies, and for the design of interventions with potential disease-modifying agents
Freddie Krubber--- Nightmare on elmstreet
Onset â 3-6 years age
Slowly increasing till 13-14 years age
In males then decreases
Females- continues increasing â peak -20-29 years
Slow decline after that
Traumatic events are known to induce nightmares, sometimes immediately, but at other times delayed. The nightmares can persist for many years
Several medications are known to sometimes provoke nightmares, including L-DOPA and β-adrenergic blockers, and so does withdrawal from REM suppressant medications. Finally, drug or alcohol abuse is associated with nightmares.
Repeated extended, extremely dysphoric and well remembered dreams- involve-efforts to avoid threats to security/survival/physical integrity
Not d/t physiological effects of a substance / co-existing medical or mental disorder
Long complicated â increasingly frightening
Story like sequence
Efforts to avoid threats
REM â 2nd half
On awakening â orientated, alert
Autonomic arousal
Frequently occurring nightmares often produce a âfear of sleepingâ type of insomnia. In turn, the insomnia may provoke sleep deprivation, which is known to exacerbate nightmares. In this manner, a vicious cycle is created
A lucid dream is any dream during which the dreamer is aware that they are dreaming. During lucid dreaming, the dreamer may be able to exert some degree of control over the dream characters, narrative, and environment.
Evidence for the use of prazosin (Minipress), a central nervous system Îą-1âreceptor antagonist, in the treatment of posttraumatic stress disorderârelated nightmares is growing. Prazosin significantly increased total sleep time and REM sleep time and significantly reduced trauma-related nightmares and distressed awakenings
AASM- 2010 guidelines- Prazosin is recommended for treatment of Posttraumatic Stress Disorder (PTSD)-associated nightmares. (Level A- recommended)
Image Rehearsal Therapy (IRT) is recommended for treatment of nightmare disorder. Level A
Systematic Desensitization and Progressive Deep Muscle Relaxation training are suggested for treatment of idiopathic nightmares. Level B Venlafaxine is not suggested for treatment of PTSD-associated nightmares. Level B
Sleep paralysis is the inability to make voluntary movements during sleepâ itâs a normal phenomenon.
It becomes a parasomnia when it occurs at sleep-wake transitions ie either sleep onset/ awakening
At such transitions individual is conscious and aware of the surroundings â and subjective experience of being unable to move results in marked distress or frightening
Duration 1- several minutes
and strange feelings in the form of â someone sitting over the chest
Sleep paralysis is the inability to make voluntary movements during sleep.
It becomes a parasomnia when it occurs at sleep-wake transitions ie either sleep onset/ awakening
At such transitions individual is conscious and aware of the surroundings â and being unable to move due to intrusion of sleep paralysis into that awake phase results in marked distress or frightening
Duration 1- several minutes and strange feelings in the form of â someone sitting over the chest
The night hag or old hag is a fantasy creature from the folklore of European/ Scandanavian which is used to explain the phenomenon of sleep paralysis. It is a phenomenon during which a person feels a presence of a supernatural malevolent being which immobilizes the person as if sitting on his/her chest or the foot of his/hers bed
interpretation
total score < 0 - very unlikely to be epilepsy
1-3 indeterminate â needs further evaluation by video EEG and PSG
Score > 3Very likely to be NFLE)
Exploding Head Syndrome
Individuals with this parasomnia âhearâ a loud imagined noise or a sense of a violent explosion in the head just as they are about to fall asleep or during a nocturnal awakening. The experience can occur just once or recurrently. There is no pain associated with the noise, but the individual may be concerned about are having a stroke or that something is very wrong. Even a single episode can trigger severe insomnia. There are no known neurological consequences to this syndrome
Sleep enuresis is a disorder in which the individual urinates during sleep while in bed. Bedwetting, as it is commonly called, has primary and secondary forms.
In children, primary sleep enuresis is the continuance of bedwetting since infancy.
Secondary enuresis refers to relapse after toilet training was complete and there was a period during which the child remained dry. Usually, after toilet training bedwetting spontaneously resolves before age 6 years.
Prevalence progressively declines from 30 percent at age 4 years, to 10 percent at age 6 years, to 5 percent at age 10 years, and to 3 percent at age 12 years. Parental primary enuresis increases the likelihood that the children will also have enuresis. A single recessive gene is suspected.
Secondary enuresis in children may occur with the birth of a sibling and represent a âcry for attention.â Secondary enuresis can also be associated with nocturnal seizures, sleep deprivation, and urological anomalies.
In adults, sleep enuresis is sometimes seen in patients with sleep-disordered breathing. In most cases, embarrassment, shame, and guilt are the most serious consequences. Nonetheless, if sleep enuresis is not addressed, it may leave psychosocial scars.
A variety of medications have been used to treat sleep enuresis, including imipramine, oxybutynin chloride, and synthetic vasopressin.
Behavioral treatments, including bladder training, using conditioning devices (bell and pad), and fluid restriction, have reportedly had good success when properly administered. Other treatments include psychotherapy, motivational strategies, and hypnotherapy
Sleep-related hallucinations are typically visual images occurring at sleep onset (hypnagogic) or on awakening (hypnopompic) from sleep. Sometimes difficult to differentiate from dreams, they are common in patients with narcolepsy. Complex hallucinations are rare and usually happen with abrupt awakening and without remembrance dreaming. Images tend to be vivid and immobile and persists for several minutes (usually disappearing when a light is turned on). The images can be frightening.
Sleep-Related Groaning (Catathrenia)
This disorder is a chronic condition characterized by prolonged, frequently loud groans during sleep. The groaning occurs can occur in any sleep stage. The parasomnia may begin during childhood but often remains occult until the child has to share a room. Catathrenia is not related to any psychiatric or physiologic abnormalities. There is no known treatment, and it reportedly does not improve with CPAP therapy. Polysomnography with respiratory-sound monitoring reveals sounds during exhalation and respiratory dysrhythmia
Contrary to snoring which occurs during inhalation, groaning occurs during exhalation, and one groan can last as long as 30 seconds. The groans are usually succeeded by a snort or sigh at the end. Groaning usually comes and goes in stretches, with any one stretch lasting as long as an hour
Seizure disorder should always be on the top of a differential diagnosis list for most parasomnias. In fact, the American Academy of Sleep Medicine practice guidelines concerning the indications for polysomnography include using sleep testing to rule out seizures when diagnosing sleep terror, sleepwalking, RBD, nightmares, and other parasomnias (Fig. 20-8). Sleep-related breathing disorders are also known to trigger sleepwalking, enuresis, sleep terror, confusional arousal, and nightmares. RBD is associated with a variety of neurological conditions, including Parkinson's disease, dementia, progressive supranuclear palsy, ShyâDrager syndrome, narcolepsy, and others
MSA- Multiple system atrophy = shy drager syndrome â degenerative neurolog condition â with clinical features similar parkinsons dis and autonomic dysfunction â loss of bladder control
Many drugs and substances can trigger parasomnias, particularly those agents that lighten sleep; however, alcohol is notorious for producing sleepwalking (even in individuals who have taken sleeping pills). RBD can be provoked or worsened by biperiden (Akinetin), tricyclic antidepressants, MAOIs, caffeine, venlafaxine (Effexor), selegiline (Eldepryl), and serotonin agonists. RBD may also occur during withdrawal from alcohol, meprobamate, pentazocine, and nitrazepam. Medications known provoke nightmares include L-DOPA and β-blockers. Nightmares can also be caused by drug-induced REM sleep rebound (e.g., withdrawal from REM-suppressing drugs such as methamphetamine) and alcohol abuse or withdrawal